WDWendyl J. D’sOuza

Wendyl J. D’sOuza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wendyl J. D’sOuza has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia

    by W. J. D’souza, S. J. Quinn, J. L. Fryer, B. V. Taylor, D. M. Ficker, T. J. O’brien, N. Pearce, M. J. Cook

    D’Souza WJ, Quinn SJ, Fryer JL, Taylor BV, Ficker DM, O’Brien TJ, Pearce N, Cook MJ. The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia. Acta Neurol Scand: 2012: 125: 96–104. © 2011 John Wiley & Sons A/S. Objectives – To estimate the prevalence and demographic distribution of treated epilepsy in a community-based population. Materials & methods – We surveyed all residents in Tasmania, Australia, who were supplied at least one antiepileptic drug prescription between July 1, 2001 and June 30, 2002, recorded on the national prescription database. We adjusted for the effect of disease-related non-response bias by imputation methods. Results – After three mail contacts, 54.0% (4072/7541) responded, with 1774 (43.6%) indicating treatment for epilepsy, representing 86.0% of the estimated total possible cases in Tasmania. The adjusted treated epilepsy prevalence was 4.36 per 1000 (95% CI 4.34, 4.39); lower in women (prevalence ratio 0.92 (95% CI 0.84, 1.00)); greater with increasing age (P < 0.001); similar in the three main geographic regions; and similar with socioeconomic status of postcode of residence. Conclusions – Although our estimates are likely to be affected by access to health services, overall treated epilepsy prevalence of 4.4 per 1000 is similar to previous studies. Our finding of high elderly prevalence has been reported in a few recent studies in developed countries and has important clinical and public health implications in populations with similar aging demographics.


  • Toothbrushing-induced epilepsy with structural lesions in the primary somatosensory area

    by W. J. D’sOuza, T. J. O’bRien, M. Murphy, N. M. Trost, M. J. Cook

    We report three patients with reflex toothbrushing-induced epilepsy associated with small circumscribed structural lesions in the primary somatosensory cortex in close proximity to the hand and speech motor areas. Sensory symptoms were observed at clinical onset with localizing focal ictal and interictal epileptiform discharges on EEG. These cases refine the localization, possible mechanisms of epileptogenesis, and classification of this reflex epilepsy.


  • The Tasmanian Epilepsy Register – A Community-Based Cohort

    by Wendyl J. D’sOuza, Jayne L. Fryer, Stephen J. Quinn, Bruce V. Taylor, David M. Ficker, Terence J. O’bRien, Neil E. Pearce, Mark J. Cook

    Background/Aims: Centralized prescription databases may provide an efficient mechanism for recruitment of community-treated disease. Methods: The Australian federal government agency, the Health Insurance Commission (HIC), invited patients to participate in the Tasmanian Epilepsy Register (TER). Eligible patients included those who received at least one anticonvulsant above a ‘reportable’ price threshold between July 1, 2001 and June 30, 2002. Patients were asked to disclose their medical indication for anticonvulsant treatment with additional demographic and prescription information obtained from the HIC. Results: 7,541 were eligible for recruitment. After two mail invitations over 6 months, 3,375 (46.6%) had responded, but TER enrollment amongst those indicating treatment for epilepsy was 1,180 (78.3%). TER participants were more likely to obtain their prescriptions exclusively from their general practitioner (70.9%) or from combined sources (19.1%) rather than from pediatrician (4.2%), neurologist (1.4%) or general physician (1.0%) sources. Patients were more likely to respond with increasing age (linear trend p < 0.001), when from a higher socioeconomic area (linear trend p < 0.001), or if their prescription was obtained from a neurologist (p < 0.001). Conclusion: The national Australian prescription database represents community-treated epilepsy and provides an effective and efficient method for patient recruitment for clinical epidemiological research.